Asymmetric cleavage of β-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

被引:98
|
作者
Ziouzenkova, Ouliana
Orasanu, Gabriela
Sukhova, Galina
Lau, Evan
Berger, Joel P.
Tang, Guangwen
Krinsky, Norman I.
Dolnikowski, Gregory G.
Plutzky, Jorge
机构
[1] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Merck Res Labs, Rahway, NJ USA
[3] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Medford, MA 02155 USA
[4] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
D O I
10.1210/me.2006-0225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Carotene and its metabolites exert a broad range of effects, in part by regulating transcriptional responses through specific nuclear receptor activation. Symmetric cleavage of beta-carotene can yield 9-cis retinoic acid (9-cisRA), the natural ligand for the nuclear receptor RXR, the obligate heterodimeric partner for numerous nuclear receptor family members. A significant portion of beta-carotene can also undergo asymmetric cleavage to yield apocarotenals, a series of poorly understood naturally occurring molecules whose biologic role, including their transcriptional effects, remains essentially unknown. We show here that beta-apo-14'-carotenal (apo14), but not other structurally related apocarotenals, represses peroxisome proliferator-activated receptors (PPAR) and RXR activation and biologic responses induced by their respective agonists both in vitro and in vivo. During adipocyte differentiation, apo14 inhibited PPAR gamma target gene expression and adipogenesis, even in the presence of the potent PPAR gamma agonist BRL49653. Apo14 also suppressed known PPAR alpha responses, including target gene expression and its known antiinflammatory effects, but not if PPAR alpha agonist stimulation occurred before apo14 exposure and not in PPAR alpha-deficient cells or mice. Other apocarotenals tested had none of these effects. These data extend current views of beta-carotene metabolism to include specific apocarotenals as possible biologically active mediators and identify apo14 as a possible template for designing PPAR and RXR modulators and better understanding modulation of nuclear receptor activation. These results also suggest a novel model of molecular endocrinology in which metabolism of a parent compound, beta-carotene, may alternatively activate (9-cisRA) or inhibit (apo14) specific nuclear receptor responses.
引用
收藏
页码:77 / 88
页数:12
相关论文
共 50 条
  • [41] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [42] Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells
    D Wang
    W Ning
    D Xie
    L Guo
    R N DuBois
    Oncogene, 2012, 31 : 1013 - 1023
  • [43] Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator
    Shalom-Barak, Tali
    Liersemann, Jaclyn
    Memari, Babak
    Flechner, Lawrence
    Devor, Caitlin E.
    Bernardo, Tiffany M.
    Kim, Suyeon
    Matsumoto, Nobuyuki
    Friedman, Scott L.
    Evans, Ronald M.
    White, John H.
    Barak, Yaacov
    MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (09)
  • [44] Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression
    Peter S Burrage
    Adam C Schmucker
    Yanqing Ren
    Michael B Sporn
    Constance E Brinckerhoff
    Arthritis Research & Therapy, 10
  • [45] Retinoid X Receptor Agonists Impair Arterial Mononuclear Cell Recruitment through Peroxisome Proliferator-Activated Receptor-γ Activation
    Sanz, Maria-Jesus
    Albertos, Fernando
    Otero, Eduardo
    Juez, Marina
    Morcillo, Esteban J.
    Piqueras, Laura
    JOURNAL OF IMMUNOLOGY, 2012, 189 (01): : 411 - 424
  • [46] Peroxisome proliferator-activated receptor α-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity
    Hellemans, Karine
    Kerckhofs, Karen
    Hannaert, Jean-Claude
    Martens, Geert
    Van Veldhoven, Paul
    Pipeleers, Daniel
    FEBS JOURNAL, 2007, 274 (23) : 6094 - 6105
  • [47] Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo
    Yamamoto, Atsuki
    Kakuta, Hiroki
    Miyachi, Hiroyuki
    Sugimoto, Yukio
    PPAR RESEARCH, 2011, 2011
  • [48] Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor retinoid X receptor heterodimers in the absence and presence of ligand
    Feige, JN
    Gelman, L
    Tudor, C
    Engelborghs, Y
    Wahli, W
    Desvergne, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 17880 - 17890
  • [49] CALRETICULIN MODULATES THE IN-VITRO DNA-BINDING BUT NOT THE IN-VIVO TRANSCRIPTIONAL ACTIVATION BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR RETINOID-X RECEPTOR HETERODIMERS
    WINROW, CJ
    MIYATA, KS
    MARCUS, SL
    BURNS, K
    MICHALAK, M
    CAPONE, JP
    RACHUBINSKI, RA
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 111 (02) : 175 - 179